295 related articles for article (PubMed ID: 30380978)
1. Epstein-Barr virus (EBV) status in colorectal cancer: a mini review.
Bedri S; Sultan AA; Alkhalaf M; Al Moustafa AE; Vranic S
Hum Vaccin Immunother; 2019; 15(3):603-610. PubMed ID: 30380978
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.
Borozan I; Zapatka M; Frappier L; Ferretti V
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093097
[TBL] [Abstract][Full Text] [Related]
3. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
[TBL] [Abstract][Full Text] [Related]
4. The Role of the Epstein-Barr virus in human disease.
Murray PG; Young LS
Front Biosci; 2002 Feb; 7():d519-40. PubMed ID: 11815292
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of Epstein-Barr virus in carcinomas of various sites.
Grinstein S; Preciado MV; Gattuso P; Chabay PA; Warren WH; De Matteo E; Gould VE
Cancer Res; 2002 Sep; 62(17):4876-8. PubMed ID: 12208733
[TBL] [Abstract][Full Text] [Related]
6. The Very Low Frequency of Epstein-Barr JC and BK Viruses DNA in Colorectal Cancer Tissues in Shiraz, Southwest Iran.
Sarvari J; Mahmoudvand S; Pirbonyeh N; Safaei A; Hosseini SY
Pol J Microbiol; 2018 Mar; 67(1):73-79. PubMed ID: 30015427
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics.
Tao Q; Young LS; Woodman CB; Murray PG
Front Biosci; 2006 Sep; 11():2672-713. PubMed ID: 16720343
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus DNA in colorectal carcinoma in Iranian patients.
Tafvizi F; Fard ZT; Assareh R
Pol J Pathol; 2015 Jun; 66(2):154-60. PubMed ID: 26247529
[TBL] [Abstract][Full Text] [Related]
9. Detection of Epstein-Barr virus in human colorectal cancer by in situ hybridazition.
Liu HX; Ding YQ; Sun YO; Liang L; Yang YF; Qi ZL; Liu JH; Xiong PX
Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):915-7. PubMed ID: 12377618
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies.
Xu M; Zhang WL; Zhu Q; Zhang S; Yao YY; Xiang T; Feng QS; Zhang Z; Peng RJ; Jia WH; He GP; Feng L; Zeng ZL; Luo B; Xu RH; Zeng MS; Zhao WL; Chen SJ; Zeng YX; Jiao Y
Theranostics; 2019; 9(4):1115-1124. PubMed ID: 30867819
[No Abstract] [Full Text] [Related]
11. Frequency of Epstein–Barr Virus DNA in Formalin-Fixed Paraffin-Embedded Tissue of Patients with Ductal Breast Carcinoma.
Sharifpour C; Makvandi M; Samarbafzadeh A; Talaei-Zadeh A; Ranjbari N; Nisi N; Azaran A; Jalilian S; Varnaseri M; Pirmoradi R; Ahmadi Angali K
Asian Pac J Cancer Prev; 2019 Mar; 20(3):687-692. PubMed ID: 30909665
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus and gastric carcinoma.
Fukayama M
Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and risk of breast cancer: a systematic review and meta-analysis.
Farahmand M; Monavari SH; Shoja Z; Ghaffari H; Tavakoli M; Tavakoli A
Future Oncol; 2019 Aug; 15(24):2873-2885. PubMed ID: 31342783
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated gastric carcinoma among patients with pernicious anemia.
Boysen T; Friborg J; Stribolt K; Hamilton-Dutoit S; Goertz S; Wohlfahrt J; Melbye M
Int J Cancer; 2011 Dec; 129(11):2756-60. PubMed ID: 21225628
[TBL] [Abstract][Full Text] [Related]
15. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC).
Liu Y; Yang W; Pan Y; Ji J; Lu Z; Ke Y
Oncotarget; 2016 Jan; 7(4):4903-14. PubMed ID: 26716899
[TBL] [Abstract][Full Text] [Related]
18. Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).
Song H; Lim Y; Im H; Bae JM; Kang GH; Ahn J; Baek D; Kim TY; Yoon SS; Koh Y
Sci Rep; 2019 Mar; 9(1):3465. PubMed ID: 30837539
[TBL] [Abstract][Full Text] [Related]
19. Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies.
Faller DV; Mentzer SJ; Perrine SP
Curr Opin Oncol; 2001 Sep; 13(5):360-7. PubMed ID: 11555713
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus Strain Variation.
Farrell PJ
Curr Top Microbiol Immunol; 2015; 390(Pt 1):45-69. PubMed ID: 26424643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
